Clinical Trials Directory

Trials / Unknown

UnknownNCT04554251

Global Impact of COVID-19 on Pulmonology Special Units

Global Impact of COVID-19 on Pulmonology Special Units (Bronchoscopy, Thoracoscopy, Ultrasonography and Sleep Lab)

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The COVID-19 pandemic is having a profound impact on the world. As of May 18, 2020, there were 4,889,287 confirmed cases and 322,683 deaths globally. The healthcare system is wrestling with a virus that threatens to overwhelm hospital capacity, while simultaneously confronting an unprecedented reduction in elective and non-essential care. A survey by the American Cancer Society showed that 50% of cancer patients and survivors reported some impact to their healthcare due to the COVID-19 epidemic. A recent survey was conducted by Forbes et al to evaluate the changes in GI and endoscopy practices in North America. However, the impact of this epidemic on Pulmonology units ( bronchoscopy, thoracoscopy, ultrsonography and sleep lab) globally has not been studied.

Conditions

Interventions

TypeNameDescription
OTHERSurveyinvited questionnaire

Timeline

Start date
2020-09-01
Primary completion
2020-12-01
Completion
2020-12-30
First posted
2020-09-18
Last updated
2020-09-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04554251. Inclusion in this directory is not an endorsement.